Martin Capital Partners’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.38M | Sell |
45,938
-78
| -0.2% | -$7.49K | 1.61% | 34 |
|
|
2026
Q1 | $4.77M | Buy |
46,016
+793
| +2% | +$89.9K | 1.77% | 34 |
|
|
2025
Q4 | $4.56M | Buy |
45,223
+39,909
| +751% | +$4.33M | 1.72% | 32 |
|
|
2025
Q3 | $655K | Sell |
5,314
-301
| -5% | -$37.4K | 0.25% | 48 |
|
|
2025
Q2 | $674K | Buy |
5,615
+3,555
| +173% | +$474K | 0.26% | 52 |
|
|
2025
Q1 | $303K | Buy |
2,060
+25
| +1% | +$3.82K | 0.36% | 49 |
|
|
2024
Q4 | $331K | Sell |
2,035
-17,561
| -90% | -$2.87M | 0.39% | 47 |
|
|
2024
Q3 | $3.19M | Sell |
19,596
-6,500
| -25% | -$963K | 1.58% | 37 |
|
|
2024
Q2 | $3.56M | Sell |
26,096
-634
| -2% | -$88K | 1.44% | 38 |
|
|
2024
Q1 | $4.09M | Sell |
26,730
-109
| -0.4% | -$16.3K | 1.57% | 38 |
|
|
2023
Q4 | $3.83M | Sell |
26,839
-391
| -1% | -$52.1K | 1.56% | 34 |
|
|
2023
Q3 | $3.57M | Buy |
27,230
+143
| +0.5% | +$21.7K | 1.5% | 35 |
|
|
2023
Q2 | $4.31M | Sell |
27,087
-330
| -1% | -$53.2K | 1.75% | 31 |
|
|
2023
Q1 | $4.34M | Buy |
27,417
+747
| +3% | +$112K | 1.8% | 31 |
|
|
2022
Q4 | $3.74M | Buy |
26,670
+776
| +3% | +$110K | 1.54% | 36 |
|
|
2022
Q3 | $3.33M | Buy |
25,894
+1,140
| +5% | +$164K | 1.54% | 35 |
|
|
2022
Q2 | $3.49M | Buy |
24,754
+1,163
| +5% | +$166K | 1.66% | 36 |
|
|
2022
Q1 | $3.28M | Buy |
23,591
+20,569
| +681% | +$3.15M | 1.5% | 36 |
|
|
2021
Q4 | $527K | Buy |
3,022
+57
| +2% | +$9.5K | 0.25% | 53 |
|
|
2021
Q3 | $491K | Buy |
2,965
+275
| +10% | +$47.4K | 0.25% | 53 |
|
|
2021
Q2 | $484K | Buy |
2,690
+62
| +2% | +$11.3K | 0.25% | 53 |
|
|
2021
Q1 | $507K | Buy |
2,628
+573
| +28% | +$110K | 0.27% | 52 |
|
|
2020
Q4 | $415K | Buy |
2,055
+125
| +6% | +$25.9K | 0.24% | 51 |
|
|
2020
Q3 | $406K | Sell |
1,930
-135
| -7% | -$30.1K | 0.27% | 45 |
|
|
2020
Q2 | $453K | Sell |
2,065
-321
| -13% | -$64.1K | 0.32% | 41 |
|
|
2020
Q1 | $413K | Buy |
2,386
+3
| +0.1% | +$496 | 0.31% | 43 |
|
|
2019
Q4 | $366K | Buy |
2,383
+797
| +50% | +$119K | 0.22% | 48 |
|
|
2019
Q3 | $241K | Buy |
1,586
+135
| +9% | +$21.3K | 0.16% | 48 |
|
|
2019
Q2 | $222K | Buy |
1,451
+8
| +0.6% | +$1.22K | 0.16% | 47 |
|
|
2019
Q1 | $232K | Buy |
+1,443
| New | +$224K | 0.18% | 46 |
|
|
2018
Q4 | – | Sell |
-2,721
| Closed | -$409K | – | 50 |
|
|
2018
Q3 | $409K | Buy |
+2,721
| New | +$387K | 0.37% | 45 |
|
Other funds holding CLX
Martin Capital Partners's CLX Position: Q2 2026 in Review
Martin Capital Partners reduced its Clorox (CLX) stake by 0.17% in Q2 2026, selling an estimated $7.49K and leaving 45,938 shares worth $4.38M. The position accounts for 1.61% of the portfolio, ranked #34.
Martin Capital Partners first reported a position in CLX in Q3 2018 and has held it in 31 quarters since. The position peaked at $4.77M in Q1 2026. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Martin Capital Partners held 45,938 shares of Clorox worth $4.38M as of Q2 2026.
- Martin Capital Partners sold 78 Clorox shares in Q2 2026, an estimated $7.49K.
- Clorox made up 1.61% of Martin Capital Partners's portfolio in Q2 2026, its #34 holding.
- Martin Capital Partners first reported a position in Clorox in Q3 2018 and has held it in 31 quarters since.
- Martin Capital Partners's Clorox position peaked at $4.77M in Q1 2026.
- 1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Martin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.